An Overview of the Surgical Management of Hepatic Neuroendocrine Metastases

Neuroendocrine tumours (NET) frequently metastasise to the liver (NLM) and are associated with significant morbidity and mortality. Numerous treatment options have been implemented both for cure, and to implement disease control. Surgical treatment includes curative resection, palliative cytoreducti...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of surgical oncology 2012-03, Vol.3 (1), p.20-25
Main Authors: Pathak, S., Dash, I., Taylor, M. R., Poston, G. J.
Format: Article
Language:English
Subjects:
Medicine
Medicine & Public Health
Oncology
Review
Review Article
Surgery
Surgical Oncology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neuroendocrine tumours (NET) frequently metastasise to the liver (NLM) and are associated with significant morbidity and mortality. Numerous treatment options have been implemented both for cure, and to implement disease control. Surgical treatment includes curative resection, palliative cytoreductive resection and transplantation. Complete surgical resection is only possible in a subset of people with NLMs due to excessive metastatic burden and anatomical location. Ablative therapies may be used either as an adjunct to surgery or as a primary treatment. The purpose of the following article is to summarise surgical treatment strategies in the management of patients with hepatic neuroendocrine metastases, based on the available literature.
ISSN:0975-7651
0976-6952
DOI:10.1007/s13193-012-0133-7